These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 15815218)

  • 21. Helicobacter pylori eradication may induce de novo, but transient and mild, reflux esophagitis: Prospective endoscopic evaluation.
    Take S; Mizuno M; Ishiki K; Nagahara Y; Yoshida T; Yokota K; Oguma K; Okada H; Yamamoto K
    J Gastroenterol Hepatol; 2009 Jan; 24(1):107-13. PubMed ID: 18823429
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Helicobacter pylori: a human pathogen.
    Harris A; Misiewicz JJ
    Lancet; 1995 Jun; 345(8964):1579. PubMed ID: 7791470
    [No Abstract]   [Full Text] [Related]  

  • 23. One-week dual therapy with ranitidine bismuth citrate and clarithromycin for the treatment of Helicobacter pylori infection in Brazilian patients with peptic ulcer.
    Mesquita MA; Lorena SL; Almeida JR; Montes CG; Guerrazzi F; Campos LT; Zeitune JM
    World J Gastroenterol; 2005 Jun; 11(23):3566-9. PubMed ID: 15962376
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Helicobacter pylori therapy: effect on peptic ulcer disease.
    Axon AT
    J Gastroenterol Hepatol; 1991; 6(2):131-7. PubMed ID: 1912418
    [No Abstract]   [Full Text] [Related]  

  • 25. Quadruple treatments for Helicobacter pylori.
    Mascitelli L; Pezzetta F
    Lancet; 2003 Jan; 361(9351):86. PubMed ID: 12517510
    [No Abstract]   [Full Text] [Related]  

  • 26. [Peptic ulcer disease in liver cirrhosis: role of Helicobacter pylori infection and therapeutic approach].
    Mitrică D; Constantinescu R; Drug VL; Stanciu C
    Rev Med Chir Soc Med Nat Iasi; 2011; 115(1):27-32. PubMed ID: 21688556
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Importance of ranitidine in the eradication of Helicobacter pylori].
    Beglinger C
    Rev Med Suisse Romande; 1995 Oct; 115(10):795-7. PubMed ID: 7501932
    [No Abstract]   [Full Text] [Related]  

  • 28. [Methods for increasing the efficacy and safety of Helicobacter pylori eradication regimens].
    Zakharova NV
    Eksp Klin Gastroenterol; 2006; (4):59-66. PubMed ID: 17269426
    [No Abstract]   [Full Text] [Related]  

  • 29. Long-term follow-up of Helicobacter pylori eradication therapy in Vietnam: reinfection and clinical outcome.
    Wheeldon TU; Hoang TT; Phung DC; Björkman A; Granström M; Sörberg M
    Aliment Pharmacol Ther; 2005 Apr; 21(8):1047-53. PubMed ID: 15813841
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Role of anti-secretory treatment in addition to Helicobacter pylori eradication triple therapy in the treatment of peptic ulcer].
    Jung JM; Shim KN; Oh HJ; Na YJ; Jung HS; Jung SA; Yoo K
    Korean J Gastroenterol; 2008 Jan; 51(1):11-8. PubMed ID: 18349557
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Eradication of Helicobacter pylori followed by reinfection.
    Tonokatsu Y; Fukuda Y; Tsujiai T; Tamura K; Shimoyama T
    J Gastroenterol; 1996 Nov; 31 Suppl 9():75-6. PubMed ID: 8959526
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Diagnosis and treatment of Helicobacter pylori infection. Its relationship with gastrointestinal ulcer and antimicrobial resistance].
    Antelo P; Almuzara M; Avagnina A; Topor J; Barberis C; Barcia T; Araujo G; Vay C; Famiglietti A
    Medicina (B Aires); 2001; 61(5 Pt 1):545-51. PubMed ID: 11721321
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Helicobacter pylori and peptic ulcer.
    Korman MG; Tytgat GN
    Scand J Gastroenterol Suppl; 1995; 210():92-6. PubMed ID: 8578219
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Eradication of Helicobacter pylori does not reduce the incidence of gastroduodenal ulcers in patients on long-term NSAID treatment: double-blind, randomized, placebo-controlled trial.
    de Leest HT; Steen KS; Lems WF; Bijlsma JW; van de Laar MA; Huisman AM; Vonkeman HE; Houben HH; Kadir SW; Kostense PJ; van Tulder MW; Kuipers EJ; Boers M; Dijkmans BA
    Helicobacter; 2007 Oct; 12(5):477-85. PubMed ID: 17760715
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Peptic ulcer treatment today--is there a role for maintenance therapy?
    Breslin NP; O'Morain C
    Ital J Gastroenterol Hepatol; 1997 Apr; 29(2):116-21. PubMed ID: 9646190
    [No Abstract]   [Full Text] [Related]  

  • 36. Ranitidine bismuth citrate plus azithromycin for Helicobacter pylori eradication.
    Bujanda L; Muñoz C; Sánchez A; Iriondo C; Cosme A
    J Clin Gastroenterol; 2000 Apr; 30(3):337-8. PubMed ID: 10777206
    [No Abstract]   [Full Text] [Related]  

  • 37. Eradication rates of helicobacter pylori infection with second-line treatment: non-ulcer dyspepsia compared to peptic ulcer disease.
    Chung SJ; Lee DH; Kim N; Jung SH; Kim JW; Hwang JH; Park YS; Lee KH; Jung HC; Song IS
    Hepatogastroenterology; 2007 Jun; 54(76):1293-6. PubMed ID: 17629092
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Six-year follow-up after Helicobacter pylori eradication in peptic ulcer disease.
    O'Connor HJ; Stewart C; Walsh R; McGee CN; Flynn B
    Ir J Med Sci; 2001; 170(1):24-7. PubMed ID: 11440407
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Peptic ulcer disease in patients with chronic liver disease: looking beyond bugs and drugs.
    Saad RJ; Chey WD
    Gastrointest Endosc; 2005 Sep; 62(3):357-9. PubMed ID: 16111951
    [No Abstract]   [Full Text] [Related]  

  • 40. Helicobacter pylori: a human pathogen.
    Murray L; Harvey I
    Lancet; 1995 Jun; 345(8964):1579-80. PubMed ID: 7791471
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.